Skip to navigation Skip to content



About this Medication
  • Brand Name: Mayzent®
  • Chemical Name: Siponimod
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This is an oral medication in tablet form.


Mayzent® is an immune system-modulating therapy thought to act by retaining certain white blood cells in the body's lymph nodes, keeping them out of circulation and out of the central nervous system.  Mayzent® also enters the central nervous system (brain and spinal cord) where it may have direct anti-inflammatory and/or other effects.

Mayzent® is approved by the FDA for clinically isolated syndrome, relapsing forms of MS including active secondary progressive MS. 

Click here to read the Prescribing Information for healthcare providers and scroll to page 22 for the medication guide for patients. 


Novartis Patient Assistance Foundation

Financial Assistance Program

Novartis Patient Assistance Foundation